Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · QOF

Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

A device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test is an in vitro diagnostic device intended for the detection and identification of SARS-CoV-2 and other microbial agents when in a multi-target test in human clinical respiratory specimens from patients suspected of respiratory infection who are at risk for exposure or who may have been exposed to these agents. The device is intended to aid in the diagnosis of respiratory infection in conjunction with other clinical, epidemiologic, and laboratory data or other risk factors.

Product / regulatory recordCompanyPathwayDecision dateSource
GenMark Diagnostics, Inc.510(k) clearanceOct 30, 2026FDA
Cepheid510(k) clearanceOct 22, 2026FDA
Cepheid510(k) clearanceOct 2, 2026FDA
Cepheid510(k) clearanceSep 25, 2026FDA
Biofire Diagnostics510(k) clearanceSep 22, 2026FDA
Baebies, Inc.510(k) clearanceSep 11, 2026FDA
Autonomous Medical Devices Incorporated510(k) clearanceJun 12, 2026FDA
Baebies, Inc.510(k) clearanceMar 30, 2026FDA
Lex Diagnostics Limited510(k) clearanceFeb 13, 2026FDA
Source information

Follow the FDA links to view the original records.

All device categories